To examine the difference in radio-sensitivity between SAS/neo and SAS/mp53 tumor cells, the dose-modifying factor (DMF) based on the difference in TP53 status of tumor cells was calculated using the data in Figs 1–4 (Table 4). The gene discussed is TP53; the disease is neoplasm.